NXTC – Nextcure Inc
NextCure, Inc.NXTC
$6.85Name : NextCure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $18,331,354.00
EPSttm : -25.97
NextCure, Inc.
$6.85
13.04%$0.79Float Short %
2.17
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
7.22
EPS Last/This Y
8.29
EPS This/Next Y
3.51
Price
6.9
Target Price
17.5
Analyst Recom
1.67
Performance Q
21.92
Relative Volume
0.49
Beta
1.39
Ticker: NXTC
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-09-08 | NXTC | 4.92 | N/A | N/A | 0 |
| 2025-09-09 | NXTC | 5 | N/A | N/A | 0 |
| 2025-09-10 | NXTC | 5.3 | N/A | N/A | 0 |
| 2025-09-11 | NXTC | 5.2335 | N/A | N/A | 0 |
| 2025-09-12 | NXTC | 5.3957 | N/A | N/A | 0 |
| 2025-09-15 | NXTC | 5.56 | N/A | N/A | 0 |
| 2025-09-16 | NXTC | 5.77 | N/A | N/A | 0 |
| 2025-09-17 | NXTC | 5.55 | N/A | N/A | N/A |
| 2025-09-18 | NXTC | 5.66 | N/A | N/A | 0 |
| 2025-09-19 | NXTC | 5.78 | N/A | N/A | 0 |
| 2025-09-22 | NXTC | 5.61 | N/A | N/A | 0 |
| 2025-09-23 | NXTC | 5.53 | N/A | N/A | 0 |
| 2025-09-24 | NXTC | 5.74 | N/A | N/A | 0 |
| 2025-09-25 | NXTC | 5.78 | N/A | N/A | 0 |
| 2025-09-26 | NXTC | 5.7 | N/A | N/A | 0 |
| 2025-09-29 | NXTC | 5.79 | N/A | N/A | 0 |
| 2025-09-30 | NXTC | 5.86 | N/A | N/A | 0 |
| 2025-10-01 | NXTC | 5.79 | N/A | N/A | 0 |
| 2025-10-02 | NXTC | 5.7532 | N/A | N/A | 0 |
| 2025-10-03 | NXTC | 5.84 | N/A | N/A | 0 |
| 2025-10-06 | NXTC | 5.95 | N/A | N/A | 0 |
| 2025-10-07 | NXTC | 6.13 | N/A | N/A | 0 |
| 2025-10-08 | NXTC | 6.71 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-09-08 | NXTC | 4.92 | 19.0 | - | -15.59 |
| 2025-09-09 | NXTC | 5.12 | 19.0 | - | -15.59 |
| 2025-09-10 | NXTC | 5.21 | 19.0 | - | -15.59 |
| 2025-09-11 | NXTC | 5.44 | 19.0 | - | -15.59 |
| 2025-09-12 | NXTC | 5.40 | 19.0 | - | -15.59 |
| 2025-09-15 | NXTC | 5.50 | 19.0 | - | -15.59 |
| 2025-09-16 | NXTC | 5.66 | 19.0 | - | -15.59 |
| 2025-09-17 | NXTC | 5.71 | 19.0 | - | -15.59 |
| 2025-09-18 | NXTC | 5.70 | 19.0 | - | -15.59 |
| 2025-09-19 | NXTC | 5.75 | 19.0 | - | -15.59 |
| 2025-09-22 | NXTC | 5.56 | 19.0 | - | -15.59 |
| 2025-09-23 | NXTC | 5.43 | 19.0 | - | -15.59 |
| 2025-09-24 | NXTC | 5.76 | 19.0 | - | -15.59 |
| 2025-09-25 | NXTC | 5.78 | 19.0 | - | -15.59 |
| 2025-09-26 | NXTC | 5.70 | 19.0 | - | -15.59 |
| 2025-09-29 | NXTC | 5.71 | 19.0 | - | -15.59 |
| 2025-09-30 | NXTC | 5.51 | 19.0 | - | -15.59 |
| 2025-10-01 | NXTC | 5.69 | 19.0 | - | -15.59 |
| 2025-10-02 | NXTC | 5.69 | 19.0 | - | -15.59 |
| 2025-10-03 | NXTC | 5.84 | 19.0 | - | -15.59 |
| 2025-10-06 | NXTC | 6.00 | 19.0 | - | -15.59 |
| 2025-10-07 | NXTC | 6.09 | 19.0 | - | -15.59 |
| 2025-10-08 | NXTC | 6.90 | 19.0 | - | -15.59 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-09-08 | NXTC | 0.00 | -46.26 | 3.82 |
| 2025-09-09 | NXTC | 0.00 | -46.26 | 3.82 |
| 2025-09-10 | NXTC | 0.00 | -46.26 | 3.82 |
| 2025-09-11 | NXTC | 0.00 | -46.26 | 2.74 |
| 2025-09-12 | NXTC | 0.00 | -46.26 | 2.74 |
| 2025-09-15 | NXTC | 0.00 | -45.99 | 2.74 |
| 2025-09-16 | NXTC | 0.00 | -45.99 | 2.74 |
| 2025-09-17 | NXTC | 0.00 | -45.99 | 2.74 |
| 2025-09-18 | NXTC | 0.00 | -45.99 | 2.74 |
| 2025-09-19 | NXTC | 0.00 | -45.99 | 2.74 |
| 2025-09-22 | NXTC | 0.00 | -46.16 | 2.74 |
| 2025-09-23 | NXTC | 0.00 | -46.16 | 2.74 |
| 2025-09-24 | NXTC | 0.00 | -46.16 | 2.74 |
| 2025-09-25 | NXTC | 0.00 | -46.16 | 2.17 |
| 2025-09-26 | NXTC | 0.00 | -46.16 | 2.17 |
| 2025-09-29 | NXTC | 0.00 | -46.81 | 2.17 |
| 2025-09-30 | NXTC | 0.00 | -46.81 | 2.17 |
| 2025-10-01 | NXTC | 0.00 | -46.81 | 2.17 |
| 2025-10-02 | NXTC | 0.00 | -46.81 | 2.17 |
| 2025-10-03 | NXTC | 0.00 | -46.81 | 2.17 |
| 2025-10-06 | NXTC | 0.00 | -14.15 | 2.17 |
| 2025-10-07 | NXTC | 0.00 | -14.15 | 2.17 |
| 2025-10-08 | NXTC | 0.00 | -14.15 | 2.17 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-11.29
Avg. EPS Est. Current Quarter
-3.98
Avg. EPS Est. Next Quarter
-4.07
Insider Transactions
Institutional Transactions
-14.15
Beta
1.39
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
19
Sentiment Score
59
Actual DrawDown %
96
Max Drawdown 5-Year %
-98.1
Target Price
17.5
P/E
Forward P/E
PEG
P/S
P/B
0.51
P/Free Cash Flow
EPS
-25.91
Average EPS Est. Cur. Y
-15.59
EPS Next Y. (Est.)
-12.08
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.49
Return on Equity vs Sector %
-217.7
Return on Equity vs Industry %
-204.1
EPS 1 7Days Diff
2.7
EPS 1 30Days Diff
2.73
EBIT Estimation
NextCure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 43
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading